Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$553K Buy
+8,810
New +$614K 0.15% 175
2024
Q2
Sell
-2,177
Closed -$302K 183
2024
Q1
$302K Buy
+2,177
New +$274K 0.06% 170

Other funds holding DXCM

WBI Investments's DXCM Position: Q1 2026 in Review

WBI Investments opened a new position in DexCom (DXCM) in Q1 2026: 8,810 shares worth $553K. The stake represents 0.15% of the portfolio and ranks #175 among its holdings. This is a return to the name: WBI Investments previously reported a position in DXCM as recently as Q1 2024.

WBI Investments first reported a position in DXCM in Q1 2024 and has held it in 2 quarters since. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • WBI Investments held 8,810 shares of DexCom worth $553K as of Q1 2026.
  • DexCom was a new WBI Investments position in Q1 2026.
  • DexCom made up 0.15% of WBI Investments's portfolio in Q1 2026, its #175 holding.
  • WBI Investments first reported a position in DexCom in Q1 2024 and has held it in 2 quarters since.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on WBI Investments's 13F filing for Q1 2026, filed 11 May 2026.